Convergence Financial’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,994
Closed -$250K 218
2025
Q4
$250K Sell
1,994
-239
-11% -$30.4K 0.04% 170
2025
Q3
$299K Sell
2,233
-1,226
-35% -$161K 0.04% 160
2025
Q2
$470K Sell
3,459
-8
-0.2% -$1.05K 0.08% 119
2025
Q1
$460K Sell
3,467
-408
-11% -$51.9K 0.09% 100
2024
Q4
$438K Sell
3,875
-317
-8% -$36.6K 0.09% 99
2024
Q3
$478K Sell
4,192
-998
-19% -$109K 0.1% 92
2024
Q2
$539K Buy
+5,190
New +$550K 0.14% 85

Other funds holding ABT

Convergence Financial's ABT Position: Q1 2026 in Review

Convergence Financial sold out of Abbott (ABT) in Q1 2026, closing a stake of 1,994 shares — an estimated $250K sold.

Convergence Financial first reported a position in ABT in Q2 2024 and held it in 7 quarters. The position peaked at $539K in Q2 2024. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Convergence Financial reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • Convergence Financial sold 1,994 Abbott shares in Q1 2026, an estimated $250K.
  • Convergence Financial first reported a position in Abbott in Q2 2024 and held it in 7 quarters.
  • Convergence Financial's Abbott position peaked at $539K in Q2 2024.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Convergence Financial's 13F filing for Q1 2026, filed 11 May 2026.